Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome
Clinical trial NCT02670525 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02670525
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2022-05-16
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.